Effect of Functional Inhibition of BACE1 on Sensitization to γ-Irradiation in Cancer Cells
Authors:
- Keitaro NakamotoKNKeitaro Nakamoto
- Sota KikuharaSKSota Kikuhara
- Hiroaki FujimoriHFHiroaki Fujimori
- Barkha SaraswatBarkha Saraswat
- Zhongming GaoZGZhongming Gao
- Ankitha Vadi VeluAnkitha Vadi Velu
- Zongxiang ZhangZZZongxiang Zhang
- Ying TongYTYing Tong
- Shoji ImamichiSIShoji Imamichi
- Tadashige NozakiTNTadashige Nozaki
- Yasufumi MurakamiYMYasufumi Murakami
- Mitsuko MasutaniMMMitsuko Masutani
Open Access
- 2 January 2024
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (1) , 450-460
Abstract
Developing strategies for the radiosensitization of cancer cells by the inhibition of genes, which harbor low toxicity to normal cells, will be useful for improving cancer radiotherapy. Here, we focused on a β-site of amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1; β-secretase, memapsin-2). By functional inhibition of this peptidase by siRNA, it has also recently been shown that the DNA strand break marker, γH2AX foci, increased, suggesting its involvement in DNA damage response. To investigate this possibility, we knocked down BACE1 with siRNA in cancer cell lines, and sensitization to γ-irradiation was examined by a colony formation assay, γH2AX foci and level analysis, and flow cytometry. BACE1 knockdown resulted in the sensitization of HeLa, MDA-MB-231, U2OS, and SAOS cells to γ-irradiation in a diverse range. BACE1 knockdown showed a weak radiosensitization effect in osteosarcoma U2OS cells, which has a normal p53 function. HeLa and SAOS cells, which harbor p53 dysfunction, exhibited a greater level of radiosensitization. These results suggest that BACE1 may be a potential target for the radiosensitization in particular cancer cells.Keywords
Funding Information
- MEXT KAKENHI (15K14416, H23-A-43)
- National Cancer Center Research and Development Fund (15K14416, H23-A-43)
This publication has 26 references indexed in Scilit:
- Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer DiseaseJournal of Biological Chemistry, 2012
- New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsBritish Journal of Clinical Pharmacology, 2012
- Introduction: The Changing Directions of p53 ResearchGenes & Cancer, 2011
- Reduced Sodium Channel Nav1.1 Levels in BACE1-null MiceJournal of Biological Chemistry, 2011
- A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome StabilityMolecular Cell, 2009
- Radiation-induced mitotic catastrophe in PARG-deficient cellsJournal of Cell Science, 2009
- Significance of interactions of BACE1–Arg235 with its ligands and design of BACE1 inhibitors with P2 pyridine scaffoldBioorganic & Medicinal Chemistry Letters, 2009
- Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycinBiochemical and Biophysical Research Communications, 2006
- Role of Checkpoint Kinase 1 in Preventing Premature Mitosis in Response to GemcitabineCancer Research, 2005
- A Splice Variant of β-Secretase Deficient in the Amyloidogenic Processing of the Amyloid Precursor ProteinJournal of Biological Chemistry, 2001